跳至主要内容
临床试验/NCT05708040
NCT05708040已完成不适用

Open-label, Randomized, Controlled Clinical Trial to Evaluate the Efficacy of the Smart Insulin Pen Associated With a Continuous Glucose Monitoring System Compared to a Closed Loop System in Patients With Type 1 Diabetes (EBIACE-1)

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal2 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2022年8月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
48
试验地点
2
主要终点
Time in Range

研究概览

简要总结

Analysis of glycemic control, frequency of hypoglycemia, glycemic variability, patient satisfaction and patient-perceived quality of life in patients with type 1 diabetes mellitus and continuous real-time glucose monitoring, the use of a smart pen compared to a closed loop system.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnostic criteria for DM1 according to ADA
  • Candidates for both systems (closed loop or smart insulin pen) for their usual healthcare team.
  • Acceptance of participation in the study and signing of the informed consent

排除标准

  • Gestation
  • Institutionalization, serious or terminal illness or renal replacement therapy.
  • Inability to undertake the training and / or acquire the degree of knowledge to use both systems
  • Refusal to participate in the study or to sign the informed consent

结局指标

主要结局

Time in Range

时间窗: 12 months

To assess the difference on the glycemic control expressed as time in range (% of time between 70-180 mg/dl of interstitial glucose).

次要结局

  • A1c levels(12 months)
  • Time above range(12 months)
  • Health-Related Quality of Life in Patients with Type 1 Diabetes(12 months)
  • Time below range(12 months)

研究者

研究点 (2)

Loading locations...

相似试验